Australia/NZ Equities - Survey Update

Research evidence excerpt

Australia/NZ Equities - Survey Update

Illustrating continued c3% EPS CAGR into the mdium term and stable to positive valuations

CSL.AX Neutral Moderna PDUFA date for flu vaccine 5/08/2026 Y Minor negative Vaccine may be approved for patients aged >50 yrs

DMP.AX Neutral Trading update or result August Y Positive Improvements in franchisee profitability

GDG.AX Buy June quarter update (date TBC) 22/07/2026 Y 4Q headline flows solid given mandate win, but core flows to be in greater focus.

GGP.AX Buy Next major resouce drilling update 1/03/2027 Y Positive We expect a positive resource update as GGP continue to prove out resource

GMD.AX Buy Release of multi year plan 1/08/2026 Y Neutral We expect a positive reaction to production and a negative reation to capex.

GMG.AX Buy Quarter 3 earnings 26/05/2026 Y Positive We expect a strong incremnetal improvement with upside risk to guidance upgrade

GPT.AX Buy Results 17/08/2026 Y Positive Strong results and momentum in FUM outlook and underlying portfolio

HUB.AX Buy 4Q update Y Negative Potential for weaker flows because of uncertainitty

HVN.AX Sell FY26 result 28/08/2026 Y Negative Expected to show deterioration in sales and earnings

IFT.AX Buy CDC June quarter independent valuation Early July 2026 Y Positive Will provide valuation update reflecting the recent 555MW contract, likely significant upside

KAR.AX Buy Y Negative We see downside risk production and sales at the Jun quarterly

LLC.AX Buy Further asset sale announcements July 2026 Y Positive May announce more asset sales, which is a key market focus

MP1.AX Buy Further Contract Wins Y Positive See potential for further large Compute wins

NST.AX Buy FY27 Guidance 29/07/2026 Y Negative We expect NST will downgrade their KCGM target of 750-800koz in FY27 production